BackDeciphera Pharmaceuticals Overview

Deciphera Pharmaceuticals Research & Development

Research & Development expenses for DCPH.

Quarterly R&D Expenses

$57.38M
↑ 4.78% YoY

As of Mar 31, 2024

Annual R&D Expenses (TTM)

$236.74M
↑ 21.3% YoY

Trailing 12 months ending Mar 31, 2024

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin